Publikationen von 0000-0003-4340-9706
(ORCID: 0000-0003-4340-9706)

Becker, Jürgen C, Ugurel, Selma, Leiter, Ulrike, Meier, Friedegund , Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K , Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis , Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja und Schilling, Bastian (2023) Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. The Lancet 402 (10404), S. 798-808. Volltext nicht vorhanden.

Zaremba, Anne, Mohr, Peter, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Weichenthal, Michael, Terheyden, Patrick, Forschner, Andrea, Leiter, Ulrike, Ulrich, Jens, Utikal, Jochen, Welzel, Julia, Kaatz, Martin, Gebhardt, Christoffer , Herbst, Rudolf, Sindrilaru, Anca, Dippel, Edgar, Sachse, Michael, Meiss, Frank , Heinzerling, Lucie, Haferkamp, Sebastian, Weishaupt, Carsten, Löffler, Harald, Kreft, Sophia, Griewank, Klaus, Livingstone, Elisabeth, Schadendorf, Dirk, Ugurel, Selma und Zimmer, Lisa (2023) Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European Journal of Cancer 188, S. 140-151. Volltext nicht vorhanden.

Hassel, Jessica C. , Zimmer, Lisa, Sickmann, Thomas, Eigentler, Thomas K. , Meier, Friedegund , Mohr, Peter, Pukrop, Tobias, Roesch, Alexander, Vordermark, Dirk, Wendl, Christina und Gutzmer, Ralf (2023) Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. Cancers 15 (13), S. 3448. Volltext nicht vorhanden.

Schumann, Katharina, Mauch, Cornelia, Klespe, Kai‐Christian, Loquai, Carmen, Nikfarjam, Ulrike, Schlaak, Max, Akçetin, Larissa, Kölblinger, Peter, Hoellwerth, Magdalena , Meissner, Markus, Mengi, Guelcin, Braun, Andreas Dominik , Mengoni, Miriam, Dummer, Reinhard, Mangana, Joanna, Sindrilaru, Mihaela‐Anca, Radmann, Dan, Hafner, Christine, Freund, Johann, Rappersberger, Klemens, Weihsengruber, Felix, Meiss, Frank, Reinhardt, Lydia, Meier, Friedegund , Rainer, Barbara, Richtig, Erika, Ressler, Julia Maria , Höller, Christoph, Eigentler, Thomas , Amaral, Teresa, Peitsch, Wiebke K., Hillen, Uwe, Harth, Wolfgang, Ziller, Fabian, Schatton, Kerstin, Gambichler, Thilo, Susok, Laura, Maul, Lara Valeska, Läubli, Heinz, Debus, Dirk, Weishaupt, Carsten, Börger, Sevil, Sievers, Katharina, Haferkamp, Sebastian, Zenderowski, Veronika, Nguyen, Van Anh, Wanner, Marina, Gutzmer, Ralf, Terheyden, Patrick, Kähler, Katharina, Emmert, Steffen, Thiem, Alexander, Sachse, Michael, Gercken‐Riedel, Silke, Kaune, Kjell Matthias, Thoms, Kai‐Martin, Heinzerling, Lucie, Heppt, Markus Vincent, Tratzmiller, Sabine, Hoetzenecker, Wolfram, Öllinger, Angela, Steiner, Andreas, Peinhaupt, Tobias, Podda, Maurizio, Schmid, Sabine, Wollina, Uwe, Biedermann, Tilo und Posch, Christian (2023) Real‐world outcomes using PD‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland. Journal of the European Academy of Dermatology and Venereology 37 (5), S. 894-906. Volltext nicht vorhanden.

Haist, Maximilian , Stege, Henner, Rogall, Friederike, Tan, Yuqi , von Wasielewski, Imke, Klespe, Kai Christian, Meier, Friedegund , Mohr, Peter, Kähler, Katharina C, Weichenthal, Michael , Hauschild, Axel, Schadendorf, Dirk, Ugurel, Selma, Lodde, Georg, Zimmer, Lisa, Gutzmer, Ralf, Debus, Dirk, Schilling, Bastian, Kreuter, Alexander, Ulrich, Jens, Meiss, Frank , Herbst, Rudolf, Forschner, Andrea, Leiter, Ulrike, Pfoehler, Claudia, Kaatz, Martin, Ziller, Fabian, Hassel, Jessica C, Tronnier, Michael, Sachse, Michael, Dippel, Edgar, Terheyden, Patrick, Berking, Carola, Heppt, Markus V, Kiecker, Felix, Haferkamp, Sebastian, Gebhardt, Christoffer , Simon, Jan Christoph, Grabbe, Stephan und Loquai, Carmen (2023) Treatment management forBRAF-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 11 (9), e007630. Volltext nicht vorhanden.

Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian , Gutzmer, Ralf, Meier, Friedegund , Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian , Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Simon, Jan-Christoph, Herbst, Rudolf A., Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M., Terheyden, Patrick, Stadler, Rudolf, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C. und Schadendorf, Dirk (2022) Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. The Lancet 400 (10358), S. 1117-1129. Volltext nicht vorhanden.

Hauser, Katja , Kurz, Alexander, Haggenmüller, Sarah, Maron, Roman C., von Kalle, Christof , Utikal, Jochen S., Meier, Friedegund , Hobelsberger, Sarah , Gellrich, Frank F. , Sergon, Mildred , Hauschild, Axel, French, Lars E., Heinzerling, Lucie, Schlager, Justin G., Ghoreschi, Kamran , Schlaak, Max, Hilke, Franz J., Poch, Gabriela, Kutzner, Heinz, Berking, Carola, Heppt, Markus V., Erdmann, Michael, Haferkamp, Sebastian, Schadendorf, Dirk, Sondermann, Wiebke, Goebeler, Matthias, Schilling, Bastian, Kather, Jakob N. , Fröhling, Stefan, Lipka, Daniel B., Hekler, Achim, Krieghoff-Henning, Eva und Brinker, Titus J. (2022) Explainable artificial intelligence in skin cancer recognition: A systematic review. European Journal of Cancer 167, S. 54-69. Volltext nicht vorhanden.

Koch, Elias A. T., Petzold, Anne, Wessely, Anja , Dippel, Edgar, Gesierich, Anja, Gutzmer, Ralf, Hassel, Jessica C. , Haferkamp, Sebastian, Kähler, Katharina C., Knorr, Harald, Kreuzberg, Nicole, Leiter, Ulrike , Loquai, Carmen, Meier, Friedegund , Meissner, Markus , Mohr, Peter , Pföhler, Claudia, Rahimi, Farnaz, Schadendorf, Dirk , Schell, Beatrice, Schlaak, Max , Terheyden, Patrick, Thoms, Kai-Martin, Schuler-Thurner, Beatrice, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weichenthal, Michael , Ziller, Fabian, Berking, Carola und Heppt, Markus V. (2022) Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity. Cancers 14 (3), S. 518. Volltext nicht vorhanden.

Franklin, Cindy , Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Garzarolli, Marlene, Weichenthal, Michael , Pfoehler, Claudia, Herbst, Rudolf , Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa , Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne und Ugurel, Selma (2022) Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Journal for ImmunoTherapy of Cancer 10 (6), e004509. Volltext nicht vorhanden.

Kreft, Sophia, Glutsch, Valerie, Zaremba, Anne, Schummer, Patrick , Mohr, Peter, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Sachse, Michael Max, Meiss, Frank, Forschner, Andrea, Haferkamp, Sebastian, Welzel, Julia, Terheyden, Patrick, Herbst, Rudolf, Utikal, Jochen, Kaatz, Martin, Weishaupt, Carsten, Kreuter, Alexander, Debus, Dirk, Duecker, Pia, Sindrilaru, Anca, Löffler, Harald, Schley, Gaston, Weichenthal, Michael, Schadendorf, Dirk, Ugurel, Selma, Gesierich, Anja und Schilling, Bastian (2022) MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. European Journal of Cancer 167, S. 32-41. Volltext nicht vorhanden.

Maron, Roman C., Hekler, Achim, Haggenmüller, Sarah, von Kalle, Christof, Utikal, Jochen S., Müller, Verena, Gaiser, Maria, Meier, Friedegund , Hobelsberger, Sarah , Gellrich, Frank F. , Sergon, Mildred, Hauschild, Axel, French, Lars E., Heinzerling, Lucie, Schlager, Justin G., Ghoreschi, Kamran, Schlaak, Max, Hilke, Franz J., Poch, Gabriela, Korsing, Sören, Berking, Carola, Heppt, Markus V., Erdmann, Michael, Haferkamp, Sebastian, Schadendorf, Dirk, Sondermann, Wiebke, Goebeler, Matthias, Schilling, Bastian, Kather, Jakob N. , Fröhling, Stefan, Lipka, Daniel B., Krieghoff-Henning, Eva und Brinker, Titus J. (2022) Model soups improve performance of dermoscopic skin cancer classifiers. European Journal of Cancer 173, S. 307-316. Volltext nicht vorhanden.

Mohr, Peter, Scherrer, Emilie, Assaf, Chalid, Bender, Marc , Berking, Carola, Chandwani, Sheenu, Eigentler, Thomas , Grimmelmann, Imke, Gutzmer, Ralf , Haferkamp, Sebastian, Hassel, Jessica , Hauschild, Axel , Herbst, Rudolf , Jiang, Ruixuan , Kähler, Katharina, Krepler, Clemens, Kreuter, Alexander , Leiter, Ulrike, Loquai, Carmen, Meier, Friedegund , Pföhler, Claudia, Rudolph, Anja, Schadendorf, Dirk, Schiavone, Maximo, Schley, Gaston, Terheyden, Patrick, Ugurel, Selma , Ulrich, Jens, Utikal, Jochen , Weishaupt, Carsten , Welzel, Julia und Weichenthal, Michael (2022) Real-World Therapy with Pembrolizumab: Outcomes and Surrogate Endpoints for Predicting Survival in Advanced Melanoma Patients in Germany. Cancers 14 (7), S. 1804. Volltext nicht vorhanden.

Gutzmer, R., Schulze, H.‐J., Hauschild, A., Leiter, U., Meier, F. , Haferkamp, S. , Ulrich, C., Wahl, R.U., Berking, C., Herbst, R., Häckl, M. und Schadendorf, D. (2021) Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS. Journal of the European Academy of Dermatology and Venereology 35 (8), S. 1678-1685. Volltext nicht vorhanden.

Höhn, Julia, Hekler, Achim, Krieghoff-Henning, Eva , Kather, Jakob Nikolas , Utikal, Jochen Sven , Meier, Friedegund , Gellrich, Frank Friedrich , Hauschild, Axel, French, Lars , Schlager, Justin Gabriel, Ghoreschi, Kamran , Wilhelm, Tabea, Kutzner, Heinz, Heppt, Markus, Haferkamp, Sebastian , Sondermann, Wiebke, Schadendorf, Dirk, Schilling, Bastian, Maron, Roman C, Schmitt, Max, Jutzi, Tanja, Fröhling, Stefan, Lipka, Daniel B und Brinker, Titus Josef (2021) Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review. Journal of Medical Internet Research 23 (7), e20708. Volltext nicht vorhanden.